Male Genitourinary Cancers

Timur Mitin; Chris Deig; Shushan Rana; Celine Bicquart Ord; Eric K. Hansen

doi:10.1007/978-3-030-53687-9_10

Male Genitourinary Cancers

Timur Mitin
, Chris Deig
, Shushan Rana
, Celine Bicquart Ord
, Eric K. Hansen

Knight Cancer Translational Oncology Program

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Male genitourinary malignancies span a wide range from very common malignancies, such as prostate cancer, to more rare conditions, such as testicular and penile cancers. The role of radiation therapy and its integration into multidisciplinary state-of-the-art care of patients with these conditions continues to evolve. This section aims to reinforce the indications of radiation therapy and rationale of these indications backed by clinical research findings. This section has been updated to include discussion of a landmark trial ProtecT, advanced imaging modalities, and role of ablative radiotherapy in the management of oligometastatic prostate cancer.

Original language	English (US)
Title of host publication	Radiation Oncology Study Guide, Second Edition
Publisher	Springer International Publishing
Pages	383-442
Number of pages	60
ISBN (Electronic)	9783030536879
ISBN (Print)	9783030536862
DOIs	https://doi.org/10.1007/978-3-030-53687-9_10
State	Published - Jan 1 2020

Keywords

ADT
Oligometastatic
Penile cancer
Prostate cancer
Testicular cancer

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-53687-9_10

Cite this

@inbook{fb568a908aa94df1a712ebad99cc2d10,

title = "Male Genitourinary Cancers",

abstract = "Male genitourinary malignancies span a wide range from very common malignancies, such as prostate cancer, to more rare conditions, such as testicular and penile cancers. The role of radiation therapy and its integration into multidisciplinary state-of-the-art care of patients with these conditions continues to evolve. This section aims to reinforce the indications of radiation therapy and rationale of these indications backed by clinical research findings. This section has been updated to include discussion of a landmark trial ProtecT, advanced imaging modalities, and role of ablative radiotherapy in the management of oligometastatic prostate cancer.",

keywords = "ADT, Oligometastatic, Penile cancer, Prostate cancer, Testicular cancer",

author = "Timur Mitin and Chris Deig and Shushan Rana and Ord, \{Celine Bicquart\} and Hansen, \{Eric K.\}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2021.",

year = "2020",

month = jan,

day = "1",

doi = "10.1007/978-3-030-53687-9\_10",

language = "English (US)",

isbn = "9783030536862",

pages = "383--442",

booktitle = "Radiation Oncology Study Guide, Second Edition",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Male Genitourinary Cancers

AU - Mitin, Timur

AU - Deig, Chris

AU - Rana, Shushan

AU - Ord, Celine Bicquart

AU - Hansen, Eric K.

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2021.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Male genitourinary malignancies span a wide range from very common malignancies, such as prostate cancer, to more rare conditions, such as testicular and penile cancers. The role of radiation therapy and its integration into multidisciplinary state-of-the-art care of patients with these conditions continues to evolve. This section aims to reinforce the indications of radiation therapy and rationale of these indications backed by clinical research findings. This section has been updated to include discussion of a landmark trial ProtecT, advanced imaging modalities, and role of ablative radiotherapy in the management of oligometastatic prostate cancer.

AB - Male genitourinary malignancies span a wide range from very common malignancies, such as prostate cancer, to more rare conditions, such as testicular and penile cancers. The role of radiation therapy and its integration into multidisciplinary state-of-the-art care of patients with these conditions continues to evolve. This section aims to reinforce the indications of radiation therapy and rationale of these indications backed by clinical research findings. This section has been updated to include discussion of a landmark trial ProtecT, advanced imaging modalities, and role of ablative radiotherapy in the management of oligometastatic prostate cancer.

KW - ADT

KW - Oligometastatic

KW - Penile cancer

KW - Prostate cancer

KW - Testicular cancer

UR - https://www.scopus.com/pages/publications/105008677488

UR - https://www.scopus.com/pages/publications/105008677488#tab=citedBy

U2 - 10.1007/978-3-030-53687-9_10

DO - 10.1007/978-3-030-53687-9_10

M3 - Chapter

AN - SCOPUS:105008677488

SN - 9783030536862

SP - 383

EP - 442

BT - Radiation Oncology Study Guide, Second Edition

PB - Springer International Publishing

ER -

Male Genitourinary Cancers

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this